Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2018 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DUOLINGO INC | 11 | Q2 2024 | 99.8% |
INNSUITES HOSPITALITY TRUST | 11 | Q2 2024 | 0.0% |
VERA THERAPEUTICS INC. | 10 | Q1 2024 | 0.9% |
ISHARES INC | 8 | Q3 2023 | 79.8% |
NEUBASE THERAPEUTICS INC. | 8 | Q3 2023 | 1.1% |
PREDICTIVE ONCOLOGY INC. | 8 | Q3 2023 | 0.1% |
CARMELL THERAPEUTICS CORP | 4 | Q2 2024 | 0.5% |
PREDICTIVE ONCOLOGY INC | 3 | Q2 2024 | 0.0% |
NEUBASE THERAPEUTICS INC | 2 | Q1 2024 | 0.0% |
View CARNEGIE MELLON UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NeuBase Therapeutics, Inc. | July 22, 2019 | 939,412 | 5.5% |
View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-08-08 |
13F-HR | 2024-05-07 |
13F-HR | 2024-02-02 |
13F-HR | 2023-11-01 |
13F-HR | 2023-08-01 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-10 |
View CARNEGIE MELLON UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.